Concepedia

Howie Bregman

HB

Statistics

Publications

2

Citations

46

H-Index

2

Active since

2011

Affiliations

Amgen (United States)(Current)

Howie Bregman is an author at Amgen (United States) specializing in drug design, drug discovery, and potency optimization.

Publications per year

2011–2012

2

Publications

2

Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Nav1.7 antagonists

Nagasree Chakka, Howie Bregman, Bingfan Du et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 28 citations · Full text

, , +14

Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonists

Hanh Nho Nguyen, Howie Bregman, John L. Buchanan et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 18 citations · Full text

, , +12

1–2 of 2